LifePlan Financial Group’s Global X Scientific Beta US ETF SCIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,867
Closed -$58K 610
2020
Q2
$58K Hold
1,867
0.03% 231
2020
Q1
$50K Hold
1,867
0.03% 224
2019
Q4
$66K Hold
1,867
0.03% 219
2019
Q3
$63K Hold
1,867
0.03% 219
2019
Q2
$61K Hold
1,867
0.03% 224
2019
Q1
$59K Sell
1,867
-333
-15% -$10.1K 0.03% 227
2018
Q4
$61K Hold
2,200
0.04% 215
2018
Q3
$73K Hold
2,200
0.04% 211
2018
Q2
$70K Sell
2,200
-905
-29% -$28.4K 0.04% 213
2018
Q1
$96K Buy
+3,105
New +$97.4K 0.06% 170

LifePlan Financial Group's SCIU Position: Q3 2020 in Review

LifePlan Financial Group sold out of Global X Scientific Beta US ETF (SCIU) in Q3 2020, closing a stake of 1,867 shares — an estimated $58K sold.

LifePlan Financial Group first reported a position in SCIU in Q1 2018 and held it in 10 quarters. The position peaked at $96K in Q1 2018. 0 funds tracked by Wall St. Rank hold SCIU as of Q3 2020.

  • LifePlan Financial Group reported no remaining Global X Scientific Beta US ETF position as of Q3 2020 after selling out during the quarter.
  • LifePlan Financial Group sold 1,867 Global X Scientific Beta US ETF shares in Q3 2020, an estimated $58K.
  • LifePlan Financial Group first reported a position in Global X Scientific Beta US ETF in Q1 2018 and held it in 10 quarters.
  • LifePlan Financial Group's Global X Scientific Beta US ETF position peaked at $96K in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Global X Scientific Beta US ETF as of Q3 2020.

Based on LifePlan Financial Group's 13F filing for Q3 2020, filed 30 Oct 2020.